Status:
COMPLETED
Upper Extremity Lymphatic Mapping for Breast Cancer Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Axillary Lymph Node Dissection
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
This study is being done to see if lymph nodes that drain the arm also drain the breast. An axillary lymph node dissection removes lymph nodes under the arm. It is done to help prevent cancer cells fr...
Eligibility Criteria
Inclusion
- Females with Stage II invasive breast cancer and documented axillary metastases by core biopsy, clinical examination, or fine-needle aspiration who are scheduled to undergo an ALND.
- Females \> 21 years of age
Exclusion
- Prior ipsilateral axillary surgery
- Prior ipsilateral axillary radiation
- Prior ipsilateral breast cancer
- Prior ipsilateral breast radiation
- Allergy to isosulfan blue dye
- History of ipsilateral upper extremity lymphedema
- Prior history of surgical excision of the upper outer quadrant of the ipsilateral breast
- Prior history of neoadjuvant chemotherapy for current breast cancer
- Bulky axillary disease at presentation (N2)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00717886
Start Date
June 1 2008
End Date
October 1 2009
Last Update
November 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065